Jackrel Lab tackles new vaccine technology for elderly populations
In this Q&A, Meredith Jackrel describes how her lab's expertise in protein misfolding and neurodegenerative diseases has made them uniquely qualified to work on developing new vaccine technologies aimed at elderly populations.